Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Sep 30, 2011

Premium

Vermillion has appointed Donald Munroe as chief scientific officer and vice president of research and development. Eric Fung, the company's former chief scientific officer, will now serve as chief medical officer.

Munroe was previously vice president of immunoassay research and development at Beckman Coulter. Before that he held several management roles at Invitrogen and worked in pharmaceutical discovery research experience at the R.W. Johnson Pharmaceutical Research Institute.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more